NEW YORK, July 17 – Sangamo BioSciences has agreed to prepare genetically engineered cells and deliver them to Pharmacia for screening small molecule drugs, Sangamo said Tuesday.

Sangamo, of Richmond, Calif., will use its zinc finger DNA-binding protein transcription factor (ZFP TF) technology to overexpress certain proteins in cell lines. Pharmacia, based in Peapack, NJ, will take the cells and use them to screen its library of small molecule compounds to determine how well they bind with the proteins.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.